Michael Gunnar Knell Charles River Laboratories International, Inc. (CRL) insider trading activity

Michael Gunnar Knell is CSVP&Chief Accounting Officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 10,534 shares of CRL, which is worth approximately $1.49 Million. The most recent transaction as insider was on Jan 27, 2023, when has been sold 645 shares (Common Stock) at a price of $244.29 per share, resulting in proceeds of $157,567. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.5K

18.96% 3M change

26.52% 12M change

Total Value Held $1.49 Million

Michael Gunnar Knell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 27 2023	SELL Payment of exercise price or tax liability	$157,567 $244.29 p/Share	645 Reduced 7.56%	7,889 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	2,096 Added 19.72%	8,534 Common Stock
Nov 16 2022	SELL Open market or private sale	$212,544 $248.59 p/Share	855 Reduced 11.72%	6,438 Common Stock
Nov 16 2022	BUY Exercise of conversion of derivative security	$93,485 $109.34 p/Share	855 Added 10.49%	7,293 Common Stock
May 29 2022	SELL Payment of exercise price or tax liability	$13,198 $244.41 p/Share	54 Reduced 0.83%	6,438 Common Stock
May 28 2022	SELL Payment of exercise price or tax liability	$9,043 $244.41 p/Share	37 Reduced 0.57%	6,492 Common Stock
May 27 2022	BUY Grant, award, or other acquisition	-	491 Added 6.99%	6,529 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$16,216 $289.58 p/Share	56 Reduced 0.92%	6,038 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$14,974 $293.61 p/Share	51 Reduced 0.83%	6,094 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$257,910 $312.24 p/Share	826 Reduced 11.85%	6,145 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	2,741 Added 28.22%	6,971 Common Stock
Jun 04 2021	SELL Open market or private sale	$511,911 $335.24 p/Share	1,527 Reduced 26.52%	4,230 Common Stock
Jun 04 2021	BUY Exercise of conversion of derivative security	$220,743 $144.56 p/Share	1,527 Added 20.96%	5,757 Common Stock
Jun 03 2021	SELL Open market or private sale	$263,808 $329.76 p/Share	800 Reduced 15.9%	4,230 Common Stock
Jun 03 2021	BUY Exercise of conversion of derivative security	$79,904 $99.88 p/Share	800 Added 13.72%	5,030 Common Stock
May 29 2021	SELL Payment of exercise price or tax liability	$18,251 $337.99 p/Share	54 Reduced 1.26%	4,230 Common Stock
May 28 2021	BUY Grant, award, or other acquisition	-	325 Added 7.05%	4,284 Common Stock
May 01 2021	SELL Payment of exercise price or tax liability	$30,918 $332.45 p/Share	93 Reduced 2.3%	3,959 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$23,822 $283.59 p/Share	84 Reduced 2.03%	4,052 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$17,952 $289.55 p/Share	62 Reduced 1.48%	4,136 Common Stock
Feb 19 2021	SELL Open market or private sale	$119,306 $290.99 p/Share	410 Reduced 8.9%	4,198 Common Stock
Jan 29 2021	SELL Payment of exercise price or tax liability	$248,619 $260.88 p/Share	953 Reduced 17.14%	4,608 Common Stock
Jan 29 2021	BUY Grant, award, or other acquisition	-	3,162 Added 36.25%	5,561 Common Stock

MGK

Michael Gunnar Knell

CSVP&Chief Accounting Officer

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account